Gallagher, Colleagues Introduce Bipartisan Promising Pathways Act This is one of the most important (if not - THE most important) bill for brain tumor patients ever! It will drastically speed up the search for the cure, increase your treatment options, increase the amount of research being done, and hopefully decrease the cost of treatments!
We will soon ask for your help in supporting this bill. Do not do anything yet - we are trying to figure out how best to help. If anyone has experience in this area, contact me!
Al Musella, DPM
Musella Foundation
888-295-4740
Musella@virtualtrials.com
Now that patients are living longer, safety becomes very important. At the time Optune was invented, the number of long term survivors was negligible, so we did not worry about long term safety. Now that there is a chance at becoming a long term survivor, safety matters a lot! This was a study of over 11,000 patients who used Optune and they found no serious side effects other than skin irritations which were manageable.
The Musella Foundation Awards 2 Brain Tumor Research Grants What a horrible start to the fundraising year! Last year at this time we gave out 9 grants for $495,000. This year only gave out 2 grants for $59,432 with another $25-50k possibly going to be awarded soon.
However, these are good projects. unfortunately we had to reject a few other good projects. Hopefully things will get back to normal later this year.
Cancer Vaccine Plus Adoptive T-cell Therapy Placed on Fast Track Great news! This brings the vaccine closer to approval. Early reports showed over a 6 month improvement in survival, which is significant and 23% of patients had tumor reductions. Fast track designation and orphan designation mean the FDA has looked at the data and shows an interest in speeding it up.
